Literature DB >> 1800174

Ophthalmological screening for von Hippel-Lindau disease.

A T Moore1, E R Maher, P Rosen, Z Gregor, A C Bird.   

Abstract

Forty seven individuals (from 16 kindreds) without prior evidence of retinal haemangiomas underwent full ophthalmological assessment as part of a comprehensive screening programme for Von Hippel-Lindau disease. Ten were known to be affected on the basis of non-ocular involvement and 37 were at 50% risk of having the abnormal gene. Seventeen angiomas were detected in 14 individuals (six affected patients and eight at risk relatives). Regular detailed ophthalmological assessment is important for all patients with von Hippel-Lindau disease and for relatives at risk of inheriting the abnormal gene.

Entities:  

Mesh:

Year:  1991        PMID: 1800174     DOI: 10.1038/eye.1991.133

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  10 in total

Review 1.  Von Hippel-Lindau disease.

Authors:  E R Maher; A T Moore
Journal:  Br J Ophthalmol       Date:  1992-12       Impact factor: 4.638

2.  The gene for von Hippel-Lindau disease.

Authors:  E R Maher
Journal:  BMJ       Date:  1993-07-31

3.  Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis.

Authors:  Wai T Wong; Elvira Agrón; Hanna R Coleman; George F Reed; Karl Csaky; James Peterson; Gladys Glenn; W Marston Linehan; Paul Albert; Emily Y Chew
Journal:  Arch Ophthalmol       Date:  2007-02

4.  A case of von Hippel-Lindau disease with exudative maculopathy.

Authors:  Basel T Ba Arah
Journal:  Oman J Ophthalmol       Date:  2009-05

5.  Detection of germline mutations in the von Hippel-Lindau disease gene by the primer specified restriction map modification method.

Authors:  T Kishida; F Chen; M I Lerman; B Zbar
Journal:  J Med Genet       Date:  1995-12       Impact factor: 6.318

6.  Detailed genetic mapping of the von Hippel-Lindau disease tumour suppressor gene.

Authors:  F M Richards; E R Maher; F Latif; M E Phipps; K Tory; M Lush; P A Crossey; B Oostra; P Enblad; K H Gustavson
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

7.  Presymptomatic diagnosis of von Hippel-Lindau disease with flanking DNA markers.

Authors:  E R Maher; E Bentley; S J Payne; F Latif; F M Richards; M Chiano; S Hosoe; J R Yates; M Linehan; D E Barton
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

8.  Vitreoretinal Surgery and Panretinal Photocoagulation in a Patient with Multiple Large Retinal Capillary Hemangiomas (von Hippel-Lindau Disease): A Novel Approach.

Authors:  Guilherme Sturzeneker; André Maia; Melina Morales; Rubens N Belfort
Journal:  Case Rep Ophthalmol       Date:  2019-10-01

9.  Detection of retinal microvascular changes in von Hippel-Lindau disease using optical coherence tomography angiography.

Authors:  Yifan Lu; Jay C Wang; Rebecca Zeng; Tatsuo Nagata; Raviv Katz; Shizuo Mukai; John B Miller
Journal:  PLoS One       Date:  2020-02-20       Impact factor: 3.240

10.  3-D OCT angiographic evidence of Anti-VEGF therapeutic effects on retinal capillary hemangioma.

Authors:  Oscar Otero-Marquez; Toco Yp Chui; Alexander Pinhas; Maria V Castanos Toral; Davis B Zhou; Justin Migacz; Richard B Rosen
Journal:  Am J Ophthalmol Case Rep       Date:  2022-02-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.